(Q55043216)

16 June 2018

title

Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. (English)

1 reference

16 June 2018

1 reference

1 reference

8

Marcelo Bigal

1 reference

16 June 2018

2

Richard B Lipton

1 reference

PubMed ID

17300356

16 June 2018

Stephen D. Silberstein

1

object named as

Stephen D Silberstein

1 reference

16 June 2018

3

David W Dodick

1 reference

16 June 2018

12

Steven J Greenberg

1 reference

16 June 2018

author name string

Frederick G Freitag

4

1 reference

16 June 2018

Nabih Ramadan

5

1 reference

16 June 2018

Ninan Mathew

6

1 reference

16 June 2018

Jan L Brandes

7

1 reference

16 June 2018

Joel Saper

9

1 reference

16 June 2018

Steven Ascher

10

1 reference

16 June 2018

Donna M Jordan

11

1 reference

16 June 2018

Joseph Hulihan

13

1 reference

16 June 2018

Topiramate Chronic Migraine Study Group

14

1 reference

16 June 2018

publication date

1 February 2007

1 reference

16 June 2018

published in

Headache

1 reference

16 June 2018

volume

47

1 reference

16 June 2018

page(s)

170-180

1 reference

16 June 2018

issue

2

1 reference

16 June 2018

cites work

Chronic daily headache

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00684.X

Transformed or evolutive migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00684.X

Analgesic overuse among subjects with headache, neck, and low-back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00684.X

Features of medication overuse headache following overuse of different acute headache drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00684.X

Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00684.X

Topiramate for migraine prevention: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00684.X

Topiramate in migraine prevention: results of a large controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00684.X

Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00684.X

Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00684.X

Topiramate in the Treatment of Chronic Migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00684.X

Efficacy of topiramate and valproate in chronic migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00684.X

When migraine progresses: transformed or chronic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00684.X

Migraine--current understanding and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00684.X

10.1111/J.1526-4610.2006.00684.X

21 January 2018

Identifiers

DOI

1 reference

16 June 2018

PubMed ID

17300356

1 reference

16 June 2018